What are 10x Genomics, Inc.'s profit margins?

10x Genomics, Inc. (TXG) runs a 69.6% gross margin and a -6.1% operating margin, with a -3.5% net margin.

Where do 10x Genomics, Inc.'s ratios come from?

Every ratio is computed from 10x Genomics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

10x Genomics, Inc. TXG Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	69.1%+1.2pp	67.9%+1.7pp	66.2%-10.5pp	76.7%-8.2pp
Operating margin	-9.5%+22.4pp	-31.9%+11.0pp	-42.9%-10.4pp	-32.5%-21.9pp
Net margin	-6.8%+23.1pp	-29.9%+11.3pp	-41.2%-9.1pp	-32.1%-20.3pp
Returns
Return on equity	-5.8%+19.4pp	-25.2%+7.8pp	-33%-12.5pp	-20.5%-13.0pp
Return on invested capital	-14.3%+27.8pp	-42%+4.1pp	-46.1%-11.7pp	-34.4%-9.3pp
Efficiency
Asset turnover	0.7×0.0×	0.6×0.0×	0.6×+0.1×	0.5×0.0×
Liquidity
Current ratio	4.5×-0.5×	5×+0.3×	4.7×-0.2×	4.8×-1.9×
Leverage
Debt-to-equity	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Per Share
Book value per share	$6.38+8.3%	$5.90-6.8%	$6.32-10.6%	$7.08-4.5%
Valuation
Market capitalization	$2.06B+18.7%	$1.74B-73.8%	$6.63B+59.1%	$4.17B-74.9%
Price / sales	3.2×+0.4×	2.8×-7.9×	10.7×+2.6×	8.1×-25.8×
Price / book	2.6×+0.1×	2.4×-6.5×	9×+3.8×	5.2×-15.2×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about 10x Genomics, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are 10x Genomics, Inc.'s profit margins?: 10x Genomics, Inc. (TXG) runs a 69.6% gross margin and a -6.1% operating margin, with a -3.5% net margin.
Where do 10x Genomics, Inc.'s ratios come from?: Every ratio is computed from 10x Genomics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.